Texas Instruments reported a Form 144 notice of proposed sale of shares. The filing lists 40,541 shares of Common Stock associated with UBS Financial Services Inc. and identifies sales tied to an ESOP and RSU activity. The filing shows sales reported on 02/10/2026 and 02/11/2026 with a filing date of 04/24/2026.
Texas Instruments proposes resale of common shares via brokered cash transactions. The notice lists four blocks of common stock dated 01/25/2019, 01/24/2020, 01/28/2021, and 01/27/2022 totaling specified lot sizes; sale date on the form is 04/24/2026.
UBS Financial Services Inc. submitted a Form 144 notice proposing the sale of 3,625 shares of common stock of Texas Instruments. The shares originate from ESOP grants dated 01/26/2017, 01/25/2018, 01/25/2019, and 01/24/2020. The filing lists a transaction date of 04/24/2026 and shows an aggregate value of $998,770.52. The sale method is described as cash and the broker listed is UBS Financial Services Inc.
Entity reported a Form 144 notice relating to common stock.
The filing lists 15,000 shares of common stock as "Securities To Be Sold" with an associated date of 04/24/2026. It also shows an earlier option exercise dated 01/31/2020 and a reported sale of 3,144 shares on 02/05/2026 for $11,670.00.
Texas Instruments reported strong Q1 2026 results with double‑digit growth. Revenue rose to $4.83 billion from $4.07 billion, driven mainly by higher demand in the Analog and Embedded Processing segments. Net income increased to $1.55 billion, and diluted EPS climbed to $1.68 from $1.28.
Analog revenue grew 22% to $3.92 billion with operating margin of 41.7%, while Embedded Processing revenue rose 12% to $723 million and sharply improved profitability. Trailing 12‑month free cash flow reached $4.35 billion, and the company returned $6.0 billion to shareholders. TI also agreed to acquire Silicon Labs for about $7.5 billion in cash, targeting closing in the first half of 2027.
Texas Instruments reported strong first-quarter 2026 results, with revenue of $4.83 billion, up 19% from a year earlier. Net income rose to $1.55 billion and diluted earnings per share reached $1.68, a 31% increase that included a 5‑cent benefit above the company’s original guidance.
Trailing 12‑month cash flow from operations was $7.82 billion and free cash flow was $4.35 billion, up 154% year over year, helped by CHIPS Act incentives. Over the past 12 months, TI returned $6.03 billion to shareholders through dividends and buybacks and invested heavily in R&D, SG&A and capital spending. For the second quarter, TI expects revenue between $5.00 billion and $5.40 billion and EPS between $1.77 and $2.05.
Texas Instruments Incorporated reported voting results from its April 16, 2026 annual stockholder meeting. Stockholders elected all board nominees, each receiving well over 600 million votes in favor, with sizable broker non-votes recorded.
Stockholders gave advisory approval to the company’s executive compensation, with 629,949,018 votes for and 127,448,980 against. They also ratified Ernst & Young LLP as independent registered public accounting firm for 2026, with 757,840,159 votes for. A stockholder proposal to permit action by written consent was not approved, receiving 338,654,128 votes for and 417,882,720 against.
Texas Instruments Inc. senior vice president Abraham Tsedeniya filed an initial statement of holdings in company stock and options. He reports direct ownership of 21,562 shares of common stock, which includes 9,141 shares subject to restricted stock units granted under Texas Instruments’ long-term incentive plans.
He also holds multiple non-qualified stock options to buy Texas Instruments common stock at exercise prices ranging from $79.26 to $218.97 per share, with expiration dates from 2027 through 2036. These options generally became exercisable in four equal annual installments beginning with grant-related dates between January 2018 and January 2026, with one grant scheduled to become exercisable beginning January 29, 2027.
The Vanguard Group filed Amendment No. 11 to a Schedule 13G/A reporting 0 shares beneficially owned of Common Stock of Texas Instruments Inc, representing 0% of the class. The filing explains that on January 12, 2026 Vanguard underwent an internal realignment and, in reliance on SEC Release No. 34-39538 (January 12, 1998), certain subsidiaries or business divisions will report beneficial ownership separately. The filing states those subsidiaries pursue the same investment strategies previously used and that The Vanguard Group, Inc. no longer is deemed to have beneficial ownership over securities owned by those subsidiaries. The form is signed by Ashley Grim, Head of Global Fund Administration.
Texas Instruments Incorporated reported that Senior Vice President Hagop Kozanian has announced his intention to retire, effective August 31, 2026. He currently serves as a senior executive at the company. The notice simply confirms his planned retirement date and does not describe any other business or financial changes.